On January 20, 2026, Elizabeth A. Porter, serving as Sector President at Leidos Holdings, Inc. (NYSE:LDOS), divested 3,000 shares of the company's common stock. The transaction was completed at a weighted average price of $192.2117 per share, resulting in total proceeds amounting to $576,635. This sale occurred close to Leidos’ prevailing market price of $193.45, according to recent trading data.
The range of sale prices per share varied narrowly between $192.17 and $192.36. Post-transaction, Porter retains direct ownership of 38,575 shares in Leidos, which presently holds a market capitalization valued at $24.73 billion. Notably, Leidos has upheld dividend distributions for 14 straight years and has successfully increased its dividend payouts consecutively over the past seven years, with the current dividend yield measured at 0.89%.
The disposition of stock was carried out in accordance with a prearranged trading plan established on September 12, 2025, conforming with Rule 10b5-1 under the Securities Exchange Act of 1934. While this insider sale occurred, corporate share repurchases by management have been robust, reflecting an ongoing strategic effort. Furthermore, Leidos is rated as having "GOOD" financial health by InvestingPro metrics, signaling solid fiscal fundamentals.
Recent corporate developments include Leidos securing a $127 million, three-year contract to manage Hawai’i’s energy efficiency programs. This initiative encompasses oversight of the Hawai’i Energy program and the Electric Vehicle Charging Station Rebate program, emphasizing goals to lower energy expenses and reduce carbon emissions.
Additionally, Leidos has announced collaboration with OpenAI to integrate artificial intelligence capabilities within government agency operations. This partnership aligns with the company's NorthStar 2030 growth framework aimed at expanding technological innovation.
Analysts have provided varied perspectives on the company's outlook. Stifel has revised its rating from Buy to Hold, referencing concerns about future growth prospects related to contracts with the Department of Veterans Affairs concerning Compensation and Pension medical examinations. Conversely, UBS has maintained a Neutral stance, highlighting increased volumes in completed examinations within the Veterans Benefits Administration sector.
An important management change also occurred with the appointment of Ted Tanner as Leidos' new chief technology officer, effective January 5, 2026, succeeding Jim Carlini. Tanner’s selection reflects the company’s strategic efforts to augment its technology leadership and capabilities moving forward.